Nunzia Pharmaceutical Corporation Share Price Other OTC
Equities
NUNZ
US67097W1027
Pharmaceuticals
Sales 2020 | - | Sales 2021 | - | Capitalization | 170M 14.17B |
---|---|---|---|---|---|
Net income 2020 | -9M -751M | Net income 2021 | -78M -6.51B | EV / Sales 2020 | - |
Net cash position 2020 * | - 0 | Net Debt 2021 | 97.31K 8.12M | EV / Sales 2021 | - |
P/E ratio 2020 |
-94.8
x | P/E ratio 2021 |
-2.54
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 18.04% |
Managers | Title | Age | Since |
---|---|---|---|
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
President | 68 | 01/09/01 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/19/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 68 | 01/09/01 | |
Shujie Cui
CTO | Chief Tech/Sci/R&D Officer | 62 | 05/19/05 |
Sara Gonzales
CEO | Chief Executive Officer | 51 | - |
1st Jan change | Capi. | |
---|---|---|
+28.80% | 662B | |
+22.39% | 546B | |
-4.73% | 359B | |
+16.96% | 323B | |
+4.75% | 289B | |
+13.68% | 234B | |
+4.01% | 198B | |
-10.47% | 194B | |
+5.51% | 167B |